Arzneimittel – Offene Rahmenvereinbarung über Arzneimittelrabatte gemäß § 130a Abs.8 SGB V mit jederzeitiger Beitrittsmöglichkeit, sog. Zulassungsmodell 2024-08

  • Staat:
  • Stadt: Bochum
  • ID Ausschreibung: 20260010000258080
  • Lieferauftrag
  • Offenes Verfahren
  • Öffentliche Aufträge
  • Wirtschaftlichstes Angebot
Grundinformationen über Ausschreibung
  • Veröffentlicht: 15.04.2026.
  • Läuft ab: 05.08.2026. 23:59
  • Dokumentation zu: -
  • Preis dokumentation: -
  • Wert: -
  • Kategorien (CPV code):
                    33600000 - Arzneimittel
Die Unterlagen im Zusammenhang mit der Ausschreibung


15 Tage kostenlos



Arzneimittel – Offene Rahmenvereinbarung über Arzneimittelrabatte gemäß § 130a Abs.8 SGB V mit jederzeitiger Beitrittsmöglichkeit, sog. Zulassungsmodell 2024-08

Amoxicillin, Clavulansäure, Darreichungsform: FTA, TAB (ATC-Code: J01CR02); Azithromycin, Darreichungsform: FTA (ATC-Code: J01FA10); Betahistin dihydrochlorid, Darreichungsform: TAB (ATC-Code: N07CA01); Brimonidin, Darreichungsform: EDP (ATC-Code: S01EA05); Captopril, Darreichungsform: TAB (ATC-Code: C09AA01); Cefaclor, Darreichungsform: FTA, HKP (ATC-Code: J01DC04); Cefuroxim, Darreichungsform: FTA, TAB, UTA (ATC-Code: J01DC02); Cetirizin, Darreichungsform: LSE, SIR (ATC-Code: R06AE07); Cetirizin, Darreichungsform: TAB, FTA (ATC-Code: R06AE07); Clarithromycin, Darreichungsform: FTA (ATC-Code: J01FA09); Clindamycin, Darreichungsform: FTA, HKP (ATC-Code: J01FF01); Clomipramin, Darreichungsform: RET (ATC-Code: N06AA04); Co-trimoxazol, Darreichungsform: FTA, TAB (ATC-Code: J01EE01); Dexamethason, Darreichungsform: AMP (ATC-Code: H02AB02); Dexamethason, Darreichungsform: ILO (ATC-Code: H02AB02); Doxycyclin, Darreichungsform: FTA, HKP, TAB, WKA (ATC-Code: J01AA02); Fluticason 17-propionat, Darreichungsform: DOS (ATC-Code: R03BA05); Fluvastatin, Darreichungsform: RET (ATC-Code: C10AA04); Furosemid, Spironolacton, Darreichungsform: FTA, KAP, LTA, TAB (ATC-Code: C03EB01); Golimumab (ATC-Code: L04AB06); Granisetron, Darreichungsform: ILO (ATC-Code: A04AA02); Haloperidol, Darreichungsform: TAB (ATC-Code: N05AD01); Lacosamid (ATC-Code: N03AX18); Lamivudin, Zidovudin, Darreichungsform: FTA (ATC-Code: J05AR01); Lercanidipin, Darreichungsform: FTA (ATC-Code: C08CA13); Linezolid, Darreichungsform: FTA (ATC-Code: J01XX08); Maprotilin, Darreichungsform: FTA (ATC-Code: N06AA21); Methylphenidat, Darreichungsform: HVW (ATC-Code: N06BA04); Mianserin, Darreichungsform: FTA (ATC-Code: N06AX03); Molsidomin, Darreichungsform: TAB (ATC-Code: C01DX12); Nevirapin, Darreichungsform: RET (ATC-Code: J05AG01); Nifedipin (ATC-Code: C08CA05); Nitrazepam, Darreichungsform: TAB (ATC-Code: N05CD02); Pamidronsäure, Darreichungsform: IFK (ATC-Code: M05BA03); Phenoxymethylpenicillin, Darreichungsform: FTA, TAB (ATC-Code: J01CE02); Rabeprazol, Darreichungsform: TMR (ATC-Code: A02BC04); Roxithromycin, Darreichungsform: FTA, TAB (ATC-Code: J01FA06); Theophyllin, Darreichungsform: REK (ATC-Code: R03DA04); Ustekinumab (ATC-Code: L04AC05); Valaciclovir, Darreichungsform: FTA (ATC-Code: J05AB11); Valproat natrium (ATC-Code: N03AG01)



Pharmaceutical products – Offene Rahmenvereinbarung über Arzneimittelrabatte gemäß § 130a Abs.8 SGB V mit jederzeitiger Beitrittsmöglichkeit, sog. Zulassungsmodell 2024-08

Amoxicillin, Clavulansäure, Darreichungsform: FTA, TAB (ATC-Code: J01CR02); Azithromycin, Darreichungsform: FTA (ATC-Code: J01FA10); Betahistin dihydrochlorid, Darreichungsform: TAB (ATC-Code: N07CA01); Brimonidin, Darreichungsform: EDP (ATC-Code: S01EA05); Captopril, Darreichungsform: TAB (ATC-Code: C09AA01); Cefaclor, Darreichungsform: FTA, HKP (ATC-Code: J01DC04); Cefuroxim, Darreichungsform: FTA, TAB, UTA (ATC-Code: J01DC02); Cetirizin, Darreichungsform: LSE, SIR (ATC-Code: R06AE07); Cetirizin, Darreichungsform: TAB, FTA (ATC-Code: R06AE07); Clarithromycin, Darreichungsform: FTA (ATC-Code: J01FA09); Clindamycin, Darreichungsform: FTA, HKP (ATC-Code: J01FF01); Clomipramin, Darreichungsform: RET (ATC-Code: N06AA04); Co-trimoxazol, Darreichungsform: FTA, TAB (ATC-Code: J01EE01); Dexamethason, Darreichungsform: AMP (ATC-Code: H02AB02); Dexamethason, Darreichungsform: ILO (ATC-Code: H02AB02); Doxycyclin, Darreichungsform: FTA, HKP, TAB, WKA (ATC-Code: J01AA02); Fluticason 17-propionat, Darreichungsform: DOS (ATC-Code: R03BA05); Fluvastatin, Darreichungsform: RET (ATC-Code: C10AA04); Furosemid, Spironolacton, Darreichungsform: FTA, KAP, LTA, TAB (ATC-Code: C03EB01); Golimumab (ATC-Code: L04AB06); Granisetron, Darreichungsform: ILO (ATC-Code: A04AA02); Haloperidol, Darreichungsform: TAB (ATC-Code: N05AD01); Lacosamid (ATC-Code: N03AX18); Lamivudin, Zidovudin, Darreichungsform: FTA (ATC-Code: J05AR01); Lercanidipin, Darreichungsform: FTA (ATC-Code: C08CA13); Linezolid, Darreichungsform: FTA (ATC-Code: J01XX08); Maprotilin, Darreichungsform: FTA (ATC-Code: N06AA21); Methylphenidat, Darreichungsform: HVW (ATC-Code: N06BA04); Mianserin, Darreichungsform: FTA (ATC-Code: N06AX03); Molsidomin, Darreichungsform: TAB (ATC-Code: C01DX12); Nevirapin, Darreichungsform: RET (ATC-Code: J05AG01); Nifedipin (ATC-Code: C08CA05); Nitrazepam, Darreichungsform: TAB (ATC-Code: N05CD02); Pamidronsäure, Darreichungsform: IFK (ATC-Code: M05BA03); Phenoxymethylpenicillin, Darreichungsform: FTA, TAB (ATC-Code: J01CE02); Rabeprazol, Darreichungsform: TMR (ATC-Code: A02BC04); Roxithromycin, Darreichungsform: FTA, TAB (ATC-Code: J01FA06); Theophyllin, Darreichungsform: REK (ATC-Code: R03DA04); Ustekinumab (ATC-Code: L04AC05); Valaciclovir, Darreichungsform: FTA (ATC-Code: J05AB11); Valproat natrium (ATC-Code: N03AG01)